IS
Program

Alternative, Scalable Synthetic Routes for Phase II-ready Small Molecule

Pays $50,000 for a scalable, low-cost synthesis route for a Phase II drug candidate.

Undisclosed pharmaceutical company (InnoCentive 'Seeker')GlobalPrize
About

Solvers submit a written proposal covering their approach, feasibility evidence, experience and estimated timeline/cost through InnoCentive's online form; an initial evaluation of about one month is followed by up to 6 months of experimental validation for finalists. The winning solution earns a $50,000 award, but only after the Seeker validates it in the lab, and the solver must assign exclusive …

Industries covered
BiotechMedtech
Grants under Alternative, Scalable Synthetic Routes for Phase II-ready Small Molecule

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Alternative, Scalable Synthetic Routes for Phase II-ready Small Molecule
Closed

Pays $50,000 for a scalable, low-cost synthesis route for a Phase II drug candidate.

- pool